B-type natriuretic peptide is not a marker of ischemia during dobutamine stress echocardiography

J Am Soc Echocardiogr. 2007 Jan;20(1):23-6. doi: 10.1016/j.echo.2006.07.001.

Abstract

Elevated levels of B-type natriuretic peptide (BNP) have been reported in association with exercise-induced ischemia. Data regarding BNP as a marker of ischemia during dobutamine stress echocardiography (DSE) are not conclusive. This study was designed to evaluate changes in BNP during DSE. A total of 74 patients referred to rule out ischemia by DSE were enrolled in the study. All patients had DSE using standard protocol. Of 74 patients enrolled, 6 were excluded because of nondiagnostic tests. Of the remaining 68 patients, 15 had positive DSE and 53 were negative for ischemia. The BNP levels (mean +/- SD) in the patients without ischemia were 42.5 pg/mL (+/-SD 47.6) at baseline and 41.9 pg/mL (+/-SD 48.9) at peak, and the measurements in the patients with ischemia were 90 pg/mL (+/-SD 171.7) at baseline and 88 pg/mL (+/-SD 149.2) at peak. BNP levels do not change during DSE with or without evidence of ischemia.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers / blood
  • Case-Control Studies
  • Coronary Disease / diagnostic imaging*
  • Coronary Disease / physiopathology
  • Echocardiography, Stress / adverse effects
  • Echocardiography, Stress / methods*
  • Female
  • Humans
  • Logistic Models
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Myocardial Ischemia / blood*
  • Myocardial Ischemia / etiology
  • Natriuretic Peptide, Brain / analysis
  • Natriuretic Peptide, Brain / blood*
  • Prospective Studies
  • Reference Values
  • Risk Assessment
  • Sensitivity and Specificity
  • Statistics, Nonparametric

Substances

  • Biomarkers
  • Natriuretic Peptide, Brain